Veterinary Medicines

Synulox 50 mg tablets for dogs and cats

Authorised
  • Potassium clavulanate
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
SYNULOX (40+10)MG/TAB ΔΙΣΚΙΟ
Synulox 50 mg tablets for dogs and cats
Active substance:
  • Potassium clavulanate
  • Amoxicillin trihydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Potassium clavulanate
    11.91
    milligram(s)
    /
    1.00
    Tablet
  • Amoxicillin trihydrate
    45.91
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • (ID3) 500 Tablet: Box (board) with 50 Blister (aluminium; low-density polyethylene) each with 10 Tablet
  • (ID2) 100 Tablet: Box (board) with 10 Blister (aluminium; low-density polyethylene) each with 10 Tablet
  • (ID1) 10 Tablet: Box (board) with 1 Blister (aluminium; low-density polyethylene) with 10 Tablet
  • (ID4) 250 Tablet: Box (board) with 25 Blister (aluminium; low-density polyethylene) each with 10 Tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 91911/19-10-2021/K-0077401
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 2/12/2025
Download